Arranta Bio splashes $100M into ‘microbiome’ CDMO capacity with new Massachusetts facility kblankenship Tue, 09/29/2020 – 08:29
Distinguishing between newly diagnosed type 1 or type 2 diabetes can be challenging.1 As a nation, we are […]
Alongside covid-19, environmental challenges should be prioritised.1 Unfortunately, Pakistan is currently facing both types of disaster.Recent heavy rains […]
We now face a potential second wave of the covid-19 pandemic and a backlog of elective work, and […]
The blood lands on my left shoe as the needle hits its mark. The adrenaline travels slowly to […]
Treatment becomes first and only biologic for HES in the US
First subject dosed with new drug candidate from strategic collaboration
Treatment is being developed by Australian biotech Ena Respiratory
First phase will see company deploy 300 PCR instruments to the UK
